Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical    BMRN

BIOMARIN PHARMACEUTICAL (BMRN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. is a biotechnology company that develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.

Its products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Number of employees : 2 293 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Product884.52101.3%1,110100% +25.53%
Royalty and License4.360.5%6.470.6% +48.63%
Collaborative Agreement1.020.1%---
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States444.0850.8%507.5445.7% +14.29%
Europe178.7520.5%252.6322.7% +41.34%
Latin America142.3116.3%147.4713.3% +3.63%
Rest of World124.7714.3%209.2118.8% +67.68%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé632005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA582012Chief Financial Officer & Executive Vice President
Robert A. Baffi PhD, MBA622000Executive Vice President-Technical Operations
Henry J. Fuchs, MD592009President-Worldwide Research
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Elaine J. Heron PhD, MBA692002Independent Non-Executive Director
Michael G. Grey642005Independent Non-Executive Director
Richard A. Meier572006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD652007Independent Non-Executive Director
Alan J. Lewis, PhD712005Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 175,621,277 174,965,380 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 20,850,601 11.9%
The Vanguard Group, Inc. 14,377,214 8.19%
Jennison Associates LLC 12,314,357 7.02%
PRIMECAP Management Co. 9,638,644 5.49%
BlackRock Fund Advisors 9,193,860 5.24%
Sands Capital Management LLC 8,058,559 4.59%
Fidelity Management & Research Co. 6,795,877 3.87%
Baker Bros. Advisors LP 5,905,673 3.37%
SSgA Funds Management, Inc. 4,014,268 2.29%
Temasek Holdings Pte Ltd. (Investment Management) 3,472,712 1.98%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6677.88%19,066,668 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
Company contact information
BioMarin Pharmaceutical
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415 506 6700
Fax : +1 415 382 7889
Internet : http://www.bmrn.com
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICAL0.13%14 568
BIOGEN20.14%65 444
CSL LIMITED41.53%48 909
ALEXION PHARMACEUTICALS-9.38%24 238
GRIFOLS SA33.42%18 723
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%7 189
3SBIO INC98.68%4 902
ABCAM PLC25.29%2 658
BOYA BIO-PHARMACEUTICAL GROUP CO LTD--.--%1 892
HUGEL INC--.--%1 886
BIOTEST AG32.08%931
ANIKA THERAPEUTICS INC9.05%791
PROMETIC LIFE SCIENCES INC.-39.04%770
PHARMA MAR SA-9.96%638
CHEMOCENTRYX INC-1.08%351
WILSON THERAPEUTICS AB95.33%336
SYROS PHARMACEUTICALS INC1.56%336
KADMON HOLDINGS INC-31.03%290
CO DON AG274.05%241
STRONGBRIDGE BIOPHARMA PLC135.42%237
SYNDAX PHARMACEUTICALS INC22.87%208
Connections : BioMarin Pharmaceutical
Ziarco Group Ltd.
Cellastra, Inc.
Spruce Biosciences, Inc.
Reneo Pharmaceuticals, Inc.
Targazyme, Inc.
NeuraMetrix, Inc.
Zephyrus Biosciences, Inc.
Rincon Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc.
National Institute for Bioprocessing Research & Training
DiaVacs, Inc.
Reform Biologics LLC
Selventa, Inc.
Sutro Biopharma, Inc.
Balance Therapeutics, Inc.
Cytochroma, Inc.
Biothera, Inc.
Batu Biologics, Inc.
Pappas Capital LLC
Biotechnology Innovation Organization
Scancell Ltd.
Sosei Co. Ltd.
Rapidscan Pharma Solutions, Inc.
AbSci LLC
Capella Therapeutics, Inc.
Itero Biopharmaceuticals LLC
Habit DX, Inc.
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem